0001193125-23-039753.txt : 20230215 0001193125-23-039753.hdr.sgml : 20230215 20230215074804 ACCESSION NUMBER: 0001193125-23-039753 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230215 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230215 DATE AS OF CHANGE: 20230215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Calyxt, Inc. CENTRAL INDEX KEY: 0001705843 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 271967997 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38161 FILM NUMBER: 23633632 BUSINESS ADDRESS: STREET 1: 2800 MOUNT RIDGE ROAD CITY: ROSEVILLE STATE: MN ZIP: 55113 BUSINESS PHONE: (651) 683-2807 MAIL ADDRESS: STREET 1: 2800 MOUNT RIDGE ROAD CITY: ROSEVILLE STATE: MN ZIP: 55113 8-K 1 d424819d8k.htm 8-K 8-K
false 0001705843 0001705843 2023-02-15 2023-02-15

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report: (Date of earliest event reported): February 15, 2023

 

 

Calyxt, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-38161   27-1967997

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

2800 Mount Ridge Road

Roseville, MN 55113-1127

(Address and zip code of principal executive offices)

(651) 683-2807

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☒

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading

Symbol(s)

  

Name of exchange

on which registered

Common Stock, par value $0.0001 per share   CLXT   The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

Item 7.01.

Regulation FD Disclosure.

On February 15, 2023, Calyxt, Inc. (“Calyxt”) issued a press release announcing that it had filed a Registration Statement on Form S-4. A copy of the press release is furnished as Exhibit 99.1 to this report this Current Report on Form 8-K and incorporated herein by reference.

The information furnished in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed to be “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section, nor shall such information be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Cautionary Statement Regarding Forward-Looking Statements

The information included in this Current Report on Form 8-K and the materials incorporated by reference herein include “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. All statements, other than statements of present or historical fact included herein, regarding the transactions, the ability of the parties to the merger agreement to consummate the transactions, the benefits of the transactions, Calyxt’s future financial performance (including its liquidity and capital resources and cash runway), the combined company’s future performance following the transactions, and the potential for global regulatory developments, as well as Calyxt’s, Cibus’s and the combined company’s respective strategies, future operations, financial positions, prospects and plans as well as the objectives of management are forward-looking statements. Words such as “expects,” “continues,” “may,” “will,” “approximately,” “intends,” the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words.

These forward-looking statements are based on the current expectations and assumptions of Cibus’s and Calyxt’s management about future events and are based on currently available information as to the outcome and timing of future events. Forward-looking statements are subject to risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of Calyxt and Cibus. These risks include, but are not limited to, (i) the risk that the conditions to the closing of the proposed Transactions are not satisfied, including the failure to obtain stockholder approval of matters related to the proposed Transactions in a timely manner or at all, (ii) uncertainties as to the timing of the consummation of the proposed Transactions, (iii) risks related to Calyxt’s capital resources and the ability of Calyxt and Cibus, respectively, to correctly estimate and manage their respective operating expenses and expenses associated with the proposed Transactions, (iv) risks related to Calyxt’s continued listing on the Nasdaq Capital Market until closing of the proposed Transactions, (v) risks associated with the possible failure to realize certain anticipated benefits of the proposed Transactions, including with respect to future financial and operating results; (vi) uncertainties regarding the impact that any delay in the Closing would have on the anticipated cash resources of the combined company upon Closing and other events and unanticipated spending and costs that could reduce the combined company’s cash resources; (vii) the potential for the occurrence of any event, change or other circumstance or condition that could give rise to the termination of the Merger Agreement; (viii) the possible effect of the announcement, pendency or completion of the Merger on Calyxt’s or Cibus’s business relationships, operating results and business generally; (ix) risks related to unexpected costs related to the Merger; (x) the potential for, and uncertainty associated with the outcome of, any legal proceedings that may be instituted against Calyxt or Cibus or any of their respective directors or officers related to the Merger Agreement or the Transactions; (xi) risks associated with the ability of Calyxt and Cibus to protect their respective intellectual property rights; (xii) the potential impact of competitive responses to the proposed Transactions and changes in expected or existing competition; (xiii) the possibility that Calyxt, Cibus or the combined company may be adversely affected by other economic, business, or competitive factors; (xiv) risks associated with the loss of key employees of Calyxt or Cibus; (xv) risks associated with changes in applicable laws or regulations and the potential impact of such changes on Calyxt’s, Cibus’s or the combined company’s ability to advance product development and commercialization; and (xvi) other risks and uncertainties identified from time to time in documents filed or to be filed with the SEC by Calyxt or the combined company, including those discussed in the “Risk Factors” section of Calyxt’s Annual Report on Form 10-K, which was filed with the SEC on March 3, 2022, and Quarterly Reports on Form 10-Q, which were filed with the SEC on August 4, 2022 and November 3, 2022, respectively. Should one

or more of the risks or uncertainties occur, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements. In addition, the forward-looking statements included in this Current Report on Form 8-K represent Calyxt’s and Cibus’s views as of the date hereof. Calyxt and Cibus anticipate that subsequent events and developments will cause the respective company’s views to change. Calyxt and Cibus specifically disclaim any obligation to update such forward-looking statements in the future, except as required under applicable law. These forward-looking statements should not be relied upon as representing Calyxt’s or Cibus’s views as of any date subsequent to the date hereof.

Important Additional Information

In connection with the proposed transactions, Calyxt has filed materials with the Securities and Exchange Commission (the “SEC”), including a registration statement on Form S-4 (the “Form S-4”), which includes a proxy statement of Calyxt for the stockholders of Calyxt and that will serve as a prospectus of Calyxt and an information statement of Cibus, and other documents relating to the proposed transactions. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THESE MATERIALS, INCLUDING THE FORM S-4 AND THE PROXY STATEMENT/PROSPECTUS INCLUDED THEREIN BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT CALYXT, CIBUS AND THE PROPOSED TRANSACTIONS. After the Form S-4 is declared effective, the definitive proxy statement included in the Form S-4 will be mailed to Calyxt stockholders as of a record date to be established for voting on the matters to be considered at the Calyxt special meeting of stockholders being held in connection with the Transactions. The Form S-4, the proxy statement/prospectus included therein, and other materials filed by Calyxt with the SEC may be obtained free of charge from the SEC’s website (www.sec.gov) or from Calyxt by directing a request to: Calyxt, Inc., 2800 Mount Ridge Road, Roseville, MN 55113.

Participants in the Solicitation

Calyxt, Cibus and their respective directors, executive officers and other members of management may be deemed to be participants in the solicitation of proxies with respect to the proposed Transactions under the rules of the SEC. Information about the directors and executive officers of Calyxt is set forth in Calyxt’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, which was filed with the SEC on March 3, 2022, and its definitive proxy statement for its 2022 Annual Meeting of Shareholders, which was filed with the SEC on April 19, 2022.

Other information regarding persons who may, under the rules of the SEC, be deemed to be participants in the proxy solicitation and a description of their interests in the transaction, by security holdings or otherwise, are included in the proxy statement/prospectus included in the Form S-4 and other relevant materials filed with the SEC regarding the proposed transaction. Investors should read the proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from Calyxt or the SEC’s website, as indicated above.

No Offer or Solicitation

This Current Report on Form 8-K and the materials incorporated by reference herein shall not constitute an offer to sell or a solicitation of an offer to buy the securities of Calyxt, Cibus or the combined company, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offering of securities shall be made in the United States except by means of a prospectus meeting the requirements of Section 10 of the Securities Act. Subject to certain exceptions to be approved by the relevant regulators or certain facts to be ascertained, a public offer will not be made directly or indirectly, in or into any jurisdiction where to do so would constitute a violation of the laws of such jurisdiction, or by use of the mails or by any means or instrumentality (including without limitation, facsimile transmission, telephone or internet) of interstate or foreign commerce, or any facility of a national securities exchange, of any such jurisdiction.

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit

Number

   

Description

99.1    Press Release, dated February 15, 2023
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, Calyxt, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: February 15, 2023

 

CALYXT, INC.
By:  

/s/ Michael A. Carr

Name:   Michael A. Carr
Title:   President and Chief Executive Officer
 EX-99.1 2 d424819dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Calyxt, Inc. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC

ROSEVILLE, Minn. and SAN DIEGO– Feb. 15, 2023 /PRNewswire/ — Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, and Cibus, a leader in precision gene editing in agriculture, today announced that Calyxt has filed a registration statement on Form S-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) on February 14, 2023. The combined company is expected to be renamed Cibus, Inc. and remain listed on the Nasdaq Capital Market under the proposed ticker symbol CBUS.

The Registration Statement contains a preliminary proxy statement / prospectus in connection with the previously announced merger of Calyxt and Cibus. Although the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about Calyxt and the proposed transactions.

The entering into a definitive merger agreement was announced on January 17, 2023. The merger is expected to close in the second quarter of 2023, subject to customary closing conditions, including approval of the merger by the shareholders of Calyxt.

About Calyxt

Calyxt (Nasdaq: CLXT) is a plant-based synthetic biology company. Calyxt leverages its proprietary PlantSpring™ technology platform and Plant Cell Matrix™ biomass to engineer plant metabolism to produce innovative high value plant-based chemistries for use in customers’ materials and products. As plant-based solutions, Calyxt’s synthetic biology products can be used in helping customers meet their sustainability targets and financial goals. Calyxt’s diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit www.calyxt.com.

About Cibus

Cibus® is a leading agricultural technology company that develops, and licenses gene edited plant traits to seed companies. Its traits enable farmers to manage productivity and sustainability challenges such as diseases, pests, weeds, fertilizer use and climate change. Cibus’ goal is to use its trait technology to create a new generation of crops that are more adaptable to their environment and have increased yields while requiring less chemicals. Cibus’ patented RTDS® technology platform has enabled agriculture’s first standardized end-to-end gene editing trait prototype and production system: the Trait Machine™. The Trait Machine represents a technological breakthrough in plant breeding that broadens the range and scale of possible trait solutions that makes more diverse germplasm accessible, materially shortens trait breeding timelines, and shortens the time to market traits. Cibus’ technologies and traits are accelerating agriculture’s jump to a climate smart, more sustainable crop production system and the industry’s move to sustainable low-carbon ingredients. For more information, visit www.cibus.com.

Cautionary Statement Regarding Forward-Looking Statements

The information included in this press release include “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. All statements, other than statements of present or historical fact included herein, regarding the transactions, the ability of the parties to the merger agreement to consummate the transactions, the benefits of the transactions, Calyxt’s future financial performance (including its liquidity and capital resources and cash runway), the combined company’s future performance following the transactions, and the potential for global regulatory developments, as well as Calyxt’s, Cibus’s and the combined company’s respective strategies, future operations, financial positions, prospects and plans as well as the objectives of management are forward-looking statements. Words such as “expects,” “continues,” “may,” “will,” “approximately,” “intends,” the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words.

These forward-looking statements are based on the current expectations and assumptions of Cibus’s and Calyxt’s management about future events and are based on currently available information as to the outcome and timing of future events. Forward-looking statements are subject to risks and uncertainties, most of which are difficult to predict and many of which are beyond the control of Calyxt and Cibus. These risks include, but are not limited to, (i) the risk that the conditions to the closing of the proposed Transactions are not satisfied, including the failure to obtain stockholder approval of matters related to the proposed Transactions in a timely manner or at all, (ii) uncertainties as to the timing of the consummation of the proposed Transactions, (iii) risks related to Calyxt’s capital resources and the ability of Calyxt and Cibus, respectively, to correctly estimate and manage their respective operating expenses and expenses associated with the proposed Transactions, (iv) risks related to Calyxt’s continued listing on the Nasdaq Capital Market until closing of the proposed Transactions, (v) risks associated with the possible failure to realize certain anticipated benefits of the proposed Transactions, including with respect to future financial and operating results; (vi) uncertainties regarding the impact that any delay in the Closing would have on the anticipated cash resources of the combined company upon Closing and other events and unanticipated spending and costs that could reduce the combined company’s cash resources; (vii) the potential for the occurrence of any event, change or other circumstance or condition that could give rise to the termination of the Merger Agreement; (viii) the possible effect of the announcement, pendency or completion of the Merger on Calyxt’s or Cibus’s business relationships, operating results and business generally; (ix) risks related to unexpected costs related to the Merger; (x) the potential for, and uncertainty associated with the outcome of, any legal proceedings that may be instituted against Calyxt or

Cibus or any of their respective directors or officers related to the Merger Agreement or the Transactions; (xi) risks associated with the ability of Calyxt and Cibus to protect their respective intellectual property rights; (xii) the potential impact of competitive responses to the proposed Transactions and changes in expected or existing competition; (xiii) the possibility that Calyxt, Cibus or the combined company may be adversely affected by other economic, business, or competitive factors; (xiv) risks associated with the loss of key employees of Calyxt or Cibus; (xv) risks associated with changes in applicable laws or regulations and the potential impact of such changes on Calyxt’s, Cibus’s or the combined company’s ability to advance product development and commercialization; and (xvi) other risks and uncertainties identified from time to time in documents filed or to be filed with the SEC by Calyxt or the combined company, including those discussed in the “Risk Factors” section of Calyxt’s Annual Report on Form 10-K, which was filed with the SEC on March 3, 2022, and Quarterly Reports on Form 10-Q, which were filed with the SEC on August 4, 2022 and November 3, 2022, respectively. Should one or more of the risks or uncertainties occur, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements. In addition, the forward-looking statements included in this press release represent Calyxt’s and Cibus’s views as of the date hereof. Calyxt and Cibus anticipate that subsequent events and developments will cause the respective company’s views to change. Calyxt and Cibus specifically disclaim any obligation to update such forward-looking statements in the future, except as required under applicable law. These forward-looking statements should not be relied upon as representing Calyxt’s or Cibus’s views as of any date subsequent to the date hereof.

Important Additional Information

In connection with the proposed transactions, Calyxt has filed materials with the Securities and Exchange Commission (the “SEC”), including a registration statement on Form S-4 (the “Form S-4”), which includes a proxy statement of Calyxt for the stockholders of Calyxt and that will serve as a prospectus of Calyxt and an information statement of Cibus, and other documents relating to the proposed transactions. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THESE MATERIALS, INCLUDING THE FORM S-4 AND THE PROXY STATEMENT/PROSPECTUS INCLUDED THEREIN BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT CALYXT, CIBUS AND THE PROPOSED TRANSACTIONS. After the Form S-4 is declared effective, the definitive proxy statement included in the Form S-4 will be mailed to Calyxt stockholders as of a record date to be established for voting on the matters to be considered at the Calyxt special meeting of stockholders being held in connection with the Transactions. The Form S-4, the proxy statement/prospectus included therein, and other materials filed by Calyxt with the SEC may be obtained free of charge from the SEC’s website (www.sec.gov) or from Calyxt by directing a request to: Calyxt, Inc., 2800 Mount Ridge Road, Roseville, MN 55113.

Participants in the Solicitation

Calyxt, Cibus and their respective directors, executive officers and other members of management may be deemed to be participants in the solicitation of proxies with respect to the proposed Transactions under the rules of the SEC. Information about the directors and executive officers of Calyxt is set forth in Calyxt’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, which was filed with the SEC on March 3, 2022, and its definitive proxy statement for its 2022 Annual Meeting of Shareholders, which was filed with the SEC on April 19, 2022.

Other information regarding persons who may, under the rules of the SEC, be deemed to be participants in the proxy solicitation and a description of their interests in the transaction, by security holdings or otherwise, are included in the proxy statement/prospectus included in the Form S-4 and other relevant materials filed with the SEC regarding the proposed transaction. Investors should read the proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from Calyxt or the SEC’s website, as indicated above.

No Offer or Solicitation

This press release shall not constitute an offer to sell or a solicitation of an offer to buy the securities of Calyxt, Cibus or the combined company, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offering of securities shall be made in the United States except by means of a prospectus meeting the requirements of Section 10 of the Securities Act. Subject to certain exceptions to be approved by the relevant regulators or certain facts to be ascertained, a public offer will not be made directly or indirectly, in or into any jurisdiction where to do so would constitute a violation of the laws of such jurisdiction, or by use of the mails or by any means or instrumentality (including without limitation, facsimile transmission, telephone or internet) of interstate or foreign commerce, or any facility of a national securities exchange, of any such jurisdiction.

Contacts

For Calyxt:

Bill Koschak

investors@calyxt.com

651-425-1754

For Cibus:

Investor Relations:

Karen Troeber

ktroeber@cibus.com

858-450-2636

Media Relations:

Colin Sanford

colin@bioscribe.com

203-918-4347

Chris Tutino

ctutino@cibus.com

919-356-9163

EX-101.SCH 3 clxt-20230215.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 clxt-20230215_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 5 clxt-20230215_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document and Entity Information
Feb. 15, 2023
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001705843
Document Type 8-K
Document Period End Date Feb. 15, 2023
Entity Registrant Name Calyxt, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-38161
Entity Tax Identification Number 27-1967997
Entity Address, Address Line One 2800 Mount Ridge Road
Entity Address, City or Town Roseville
Entity Address, State or Province MN
Entity Address, Postal Zip Code 55113-1127
City Area Code (651)
Local Phone Number 683-2807
Written Communications true
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, par value $0.0001 per share
Trading Symbol CLXT
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 7 d424819d8k_htm.xml IDEA: XBRL DOCUMENT 0001705843 2023-02-15 2023-02-15 false 0001705843 8-K 2023-02-15 Calyxt, Inc. DE 001-38161 27-1967997 2800 Mount Ridge Road Roseville MN 55113-1127 (651) 683-2807 true false false false Common Stock, par value $0.0001 per share CLXT NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d424819d8k.htm clxt-20230215.xsd clxt-20230215_lab.xml clxt-20230215_pre.xml d424819dex991.htm http://xbrl.sec.gov/dei/2022 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d424819d8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 22 }, "contextCount": 1, "dts": { "inline": { "local": [ "d424819d8k.htm" ] }, "labelLink": { "local": [ "clxt-20230215_lab.xml" ] }, "presentationLink": { "local": [ "clxt-20230215_pre.xml" ] }, "schema": { "local": [ "clxt-20230215.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "clxt", "nsuri": "http://www.calyxt.com/20230215", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d424819d8k.htm", "contextRef": "duration_2023-02-15_to_2023-02-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d424819d8k.htm", "contextRef": "duration_2023-02-15_to_2023-02-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.calyxt.com//20230215/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001193125-23-039753-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-039753-xbrl.zip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